18th World Congress on Heart Disease - Annual Scientific Sessions 2013

  • Conference Call
  • On behalf of the Orga­niz­ing Com­mit­tee, it is a great plea­sure to invite you to par­tic­i­pate in the Inter­na­tional Acad­emy of Car­di­ol­ogy, 18th World Con­gress on Heart Dis­ease, Annual Sci­en­tific Ses­sions 2013 tak­ing place in Van­cou­ver, BC, Canada run­ning July 26 – 29, 2013.

    The Con­gress will pro­vide the oppor­tu­nity for a com­pre­hen­sive overview of the lat­est research devel­op­ments in car­dio­vas­cu­lar med­i­cine, pri­mar­ily in the areas of mol­e­c­u­lar biol­ogy, coro­nary artery dis­ease, heart fail­ure, car­diac arrhyth­mias and car­diac surgery.

    Plans for this meet­ing are pro­gress­ing extremely well. Many dis­tin­guished car­di­ol­o­gists and sci­en­tists have agreed to join the fac­ulty par­tic­i­pat­ing in this Con­gress. Papers will be pre­sented in the form of ple­nary ses­sions, sym­posia and posters, and will include superb sci­en­tific mate­r­ial orig­i­nat­ing from numer­ous lab­o­ra­to­ries around the globe, assur­ing that the meet­ing will be a major sci­en­tific event.

    Pro­gram areas will range from clin­i­cal patho­phys­i­ol­ogy to eval­u­a­tion and strat­i­fi­ca­tion tech­niques and mol­e­c­u­lar and cel­lu­lar biol­ogy, includ­ing neu­ro­hu­moral, immuno­log­i­cal and genetic stud­ies. We will dis­cuss new and inno­v­a­tive diag­nos­tic meth­ods, pre­ven­tion and treat­ment of heart dis­ease, and prog­nos­tic algo­rithms. Inte­grated into the pro­gram will be an update on the lat­est major clin­i­cal trials.

    Con­fer­ence Topics

    Mol­e­c­u­lar Car­di­ol­ogy — Basic Research

    • Apop­to­sis in vas­cu­lar and car­diac remodeling
    • Oxida­tive stress and anti-​oxidant therapy
    • Genetic deter­mi­nants of coro­nary heart disease
    • Genetic stud­ies in cardiomyopathy
    • Gene trans­fer and therapy
    • The patho­gen­e­sis of atherosclerosis
    • Extra­cel­lu­lar matrix and atherosclerosis
    • Immuno­log­i­cal prin­ci­ples in coro­nary artery disease
    • Growth con­trol and cytokines in vas­cu­lar cells
    • Neoin­ti­mal hyper­pla­sia and vas­cu­lar injury
    • Phar­ma­co­logic mod­u­la­tion of vascular-​endothelial function

    Diag­nos­tic Meth­ods

    • Bio­chem­i­cal mark­ers of acute ischemia
    • Trans­esophageal echocardiography
    • Phar­ma­co­logic stress test­ing — echocardiography
    • Echocar­dio­g­ra­phy, three-​dimensional reconstruction
    • Nuclear car­di­ol­ogy — new tech­niques to assess car­diac per­fu­sion, func­tion and viability
    • PET — new insights into myocar­dial metabolism
    • Appli­ca­tions of car­diac mag­netic res­o­nance imaging
    • CT and coro­nary calcification
    • Per­cu­ta­neous coro­nary angioscopy
    • Intravas­cu­lar ultra­sound imaging
    • Intra­coro­nary flow, doppler measurements

    Coro­nary Artery Disease

    • The plaque and acute coro­nary syndromes
    • Mech­a­nisms involved in myocar­dial stun­ning, hiber­na­tion and ischemic preconditioning
    • Acute myocar­dial infarc­tion: throm­bol­y­sis and reperfusion
    • Angio­plasty ther­apy for acute myocar­dial infarction
    • Stents: new devices/​optimal application/​multiple stents
    • Antithrom­botic and antiplatelet adjunc­tive ther­apy for PTCA
    • Block­ade of tis­sue pro­lif­er­a­tion after coro­nary interventions
    • Resteno­sis — use of ion­iz­ing radiation
    • Nitrates, beta block­ers, cal­cium entry block­ers and ACE inhi­bi­tion for myocar­dial ischemia/​infarction
    • Left ven­tric­u­lar remod­el­ing after myocar­dial infarction
    • Assess­ment of prog­no­sis, post acute myocar­dial infarction
    • Sec­ondary pre­ven­tion, risk stratification
    • Car­diac reha­bil­i­ta­tion as sec­ondary pre­ven­tion: is it worth the effort?
    • Can the progress of ath­er­o­scle­ro­sis be halted?
    • Mod­i­fi­ca­tion of lipopro­teins and coro­nary disease
    • Hyper­ten­sion, new ther­a­peu­tic approaches
    • Dia­betes mel­li­tus, obe­sity, insulin and atherosclerosis
    • Men­tal stress: its effect on car­dio­vas­cu­lar health
    • Pri­mary pre­ven­tion of coro­nary artery dis­ease in the healthy adult
    • Hor­mone ther­apy in post­menopausal women: does it alter coro­nary risk?
    • Pre­ven­tion in children

    Heart Failure

    • Neu­ro­hu­moral, immuno­logic and cytokine aspects of heart failure
    • Nitric oxide and nitric oxide syn­thase in heart failure
    • Myocyte and recep­tor abnor­mal­i­ties in heart failure
    • Natri­uretic pep­tides, endothe­lin: role in heart failure
    • Inflam­ma­tory medi­a­tors and heart failure
    • Dilated car­diomy­opa­thy: var­i­ous etiologies
    • Ischemic car­diomy­opa­thy
    • Left ven­tric­u­lar hyper­tro­phy and hyper­trophic cardiomyopathy
    • Role of the peri­cardium, peri­cardi­tis and restric­tive cardiomyopathy
    • Patho­phys­i­o­logic and prog­nos­tic insights in valvu­lar heart disease
    • Pul­monary cir­cu­la­tion aspects, pul­monary hypertension
    • Pre­dic­tors and mark­ers of heart fail­ure outcome
    • Exer­cise phys­i­ol­ogy in heart failure
    • Renal aspects — diuretics
    • Digoxin and other new inotropic agents in heart failure
    • ACE inhibitors and Angiotensin-​ll recep­tor blockers
    • Beta-​blockers and beta-​adrenergic recep­tors in heart failure
    • Cal­cium chan­nel block­ers and pro­mot­ers in heart failure
    • Car­diac pac­ing strate­gies in heart failure


    • Arrhyth­mias and antiar­rhyth­mic drug therapy
    • Atrial flutter/​fibrillation — elec­tro­phys­i­o­logic con­cepts and clin­i­cal aspects
    • Man­age­ment of car­diac arrhyth­mias pedi­atric population
    • Heart rate vari­abil­ity and prog­nos­tic implications
    • QT prolongation/​dispersion: patho­phys­i­ol­ogy and prog­nos­tic implications
    • Sud­den death
    • Elec­tro­phys­i­o­logic tech­niques of map­ping and radiofre­quency ablation
    • Advances in inter­nal defib­ril­la­tion and implantable antiar­rhyth­mic devices
    • Car­diac Pacing

    Car­diac Surgery

    • Advances in con­gen­i­tal heart disease
    • Angio­plasty or surgery for mul­ti­ves­sel coro­nary artery disease
    • New approaches to sur­gi­cal revas­cu­lar­iza­tion: Min­i­mally inva­sive surgery, TMLR
    • Ther­a­peu­tic and phys­i­o­logic issues sur­round­ing heart valve surgery
    • Mechan­i­cal sup­port left ven­tric­u­lar assist devices
    • Surgery for LV dysfunction
    • Car­diac transplantation


    • Prac­tice guide­lines, cost containment
    • Com­put­ers in cardiology
    starting: ending: 29.07.2013 Location: , Category:


    Conference START 29.07.2013 END

    All deadlines have expired!

    This conference has no more open deadlines. There may be successive conferences coming up you may by interested in.

    Please check our conference list and search...

    Conference Facts

    Location , Address Burrard St 655 Category Organiser More Info Conference Website

    Further interesting Conferences

    Currently we have no similar events listed. Please check our website regulary, subscribe to our RSS-Feed or follow us on twitter for new listings.